ExpreS2ion’s Chief Science Officer, Dr. Wian De Jongh, to Speak at World Biopharm Forum 2017 in Oxford, UK – June 27


Horsholm, Denmark, June 21, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, announces that its Chief Science Officer, Dr. Wian de Jongh, is speaking at World Biopharm 2017 in Oxford, UK, on June 27th, 2017.

World Biopharm Forum is arranging the Annual Meeting on Continuous Biomanufacturing: Current Success and Future Trend, to be held at Lady Margaret Hall, University of Oxford, Oxford, UK, on June 26-28, 2017.

This meeting provides an opportunity in sharing ExpreS2ion’s protein bioprocessing experience with a great multidisciplinary team of leading international scientists, technologists, engineers and others from across the world. Dr. Wian de Jongh will be presenting at 5.30pm GMT on June 27th, 2017, under the headline “Application of perfusion in vaccine production using Drosophila S2 insect cells”.

For further information, please contact:
ExpreS2ion Biotechnologies
Telephone: +45 4256 6869
E-mail: info@expres2ionbio.com